Results 221 to 230 of about 58,085 (295)

Association of dipeptidyl peptidase-4 inhibitor and recurrent pancreatitis risk among patients with type 2 diabetes: A retrospective cohort study. [PDF]

Front Pharmacol
Yang YS, Kornelius E, Wang YH, Lo SC, Huang CN.   +4 more
europepmc   +1 more source

Long-term prospects of therapy with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus

T. Yu. Demidova
openalex   +2 more sources

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus. [PDF]

Diabetol Int
Yoneda C, Kobayashi J, Kuribayashi N.
europepmc   +1 more source

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

HYPERTENSION, 2016
W. White, Craig A. Wilson, G. Bakris, R. Bergenstal, C. Cannon, W. Cushman, S. Heller, C. Mehta, S. Nissen, F. Zannad, S. Kupfer   +10 more
semanticscholar   +1 more source

Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial

Diabetes Care, 2015
M. Laakso, J. Rosenstock, P. Groop, A. Barnett, B. Gallwitz, U. Hehnke, I. Tamminen, Sanjay R. Patel, M. von Eynatten, H. Woerle   +9 more
semanticscholar   +1 more source

The Relationship between Bullous Pemphigoid, Diabetes Mellitus, and the Use of Dipeptidyl Peptidase-4 Inhibitors

, 2019
Tae HARADA, Mikiko Tohyama, Keiko Matsumoto, Kentaro Izumi, Wataru Nishie, Koji Sayama   +5 more
openalex   +1 more source

Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes. [PDF]

J Clin Med
Nagayama D, Kawana H, Watanabe Y, Horikawa O, Ohira M, Saiki A.   +5 more
europepmc   +1 more source

Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan [PDF]

Ryo Suzuki, Shingo Shoji, Yoko Yoshinaga, Yoshinori Kosakai, Mami Shintani‐Tachi   +4 more
openalex   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Cognitive Functions, Brain-Derived Neurotrophic Factor, and Pentraxin-3 Levels in Patients With Type 2 Diabetes. [PDF]

Cureus
Demirkılıç O, Eski İ, Çiftçi Öztürk E, Yasun Ö, Aydın B, Birkan C, Özsoy A, Şen S.   +7 more
europepmc   +1 more source